Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Supelco™ Astec™ CYCLOBOND™ II Chiral HPLC Column, 5 μm Particle Size

Catalog No. 111006231 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Length (Metric):
15 cm
25 cm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Length (Metric)
11-100-6231 15 cm
11-100-6031 25 cm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. 11-100-6231 Supplier MilliporeSigma™ Supelco™ Supplier No. 46023AST
Only null left
Add to Cart
Add to Cart

CYCLOBOND™ II is an excellent chiral selector for multi-ring structures.

Consisting of eight glucopyranose units arranged in a truncated cone shape, CYCLOBOND™ II is an excellent chiral selector for multi-ring structures. It is useful for isomeric compounds based on anthracene, chrysene and pyrene type ring structures. CYCLOBOND™ II offers good selectivity and stability and is applicable to the polar organic mode of separation. Applications include steroids, porphyrins, FMOC amino acids. Bonded phase: Underivatized, native gamma-cyclodextrin
TRUSTED_SUSTAINABILITY

Specifications

Diameter (Metric) 4.6 mm
Length (Metric) 15 cm
Particle Size 5 μm
Pore Size 100 Å
Stationary Phase Cyclodextrin, Gamma-
Product Line Astec CYCLOBOND
Matrix Cyclodextrin, Gamma- Phase/Silica Particle Platform
Phase Chiral
Technique Chiral HPLC

Astec and CYCLOBOND are registered trademarks of Sigma-Aldrich Co. LLC

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.